Current Treatment Options for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Investigators summarize current literature surrounding the treatment of NLPHL and discuss treatment considerations for 2 clinical cases.
Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
No Need for Radiotherapy in Hodgkin Lymphoma With Negative PET Scan
Even patients with bulky disease had no difference in survival after chemotherapy, provided their PET scan was negative. -
Targeted Therapies, Immunotherapies, Immunomodulators: A Quick Guide to Cancer Therapy Descriptions
Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins. -
Multicenter Study of Spanish Patients Provides New Insights on COVID-19 in Multiple Myeloma
In addition to age, sex, and comorbidities, a new study flagged uncontrolled cancer and renal insufficiency as key prognostic factors for COVID-19 outcomes. -
On-Body Injections of Pegfilgrastim May Not Always Be Preferred — But They’re On Schedule
Preferences are tied not just to the experience of receiving an injection, but also to factors related to a patient’s access to different types of care settings.
HEMATOLOGIC CANCER NEWS
HCT Deemed More Favorable for MDS That Is High Risk
Myelodysplastic Syndromes: Gene Expression Signatures May Predict Response to Azacitidine
Risk Factors for Early Relapse of DLBCL After CAR-T Therapy
Chemotherapy-Free Combination Therapy Targeted to the Epigenome in PTCL
Loncastuximab Tesirine Gets Priority Review for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
